Abstract:INTRODUCTION: Non-alcoholic fatty liver disease (NAFLD) is recognized as the most prevalent liver abnormality in the United States, with nearly 10% of the population demonstrating some form of the disease. Incidence can reach as high as 70% in patients who are obese and/or have type II diabetes [1]. Many rodent models have been developed to study NAFLD, which are induced by both diet and genetic manipulation [2]. The methionine choline deficient (MCD) model has been used to develop NAFLD, with onset of disease readily visible after 2 weeks on the diet. Changes in reduction and oxidation (redox) have been implicated in the development of this disease as well as its response to therapy [3]. Methods to detect redox changes in these animal models non-invasively are limited. Recent development of hyperpolarized (HP) [1-C] dehydroascorbate (DHA), using the dissolution dynamic nuclear polarization (DNP) technique, provides a new redox sensor to address NAFLD and its treatment. HP DHA is readily transported into the cell and reduced to Vitamin C (VitC) in vivo. The aim of this study was to use HP [1-C] DHA to image redox changes in a standard model of NAFLD and correlate these findings with standard H imaging and histopathology. METHODS: Prior to and post diet, high-resolution T2 and fat-water imaging was conducted at 14T using a Varian WB600 micro-imager and 40mm H millipede coil (Varian Instruments, Palo Alto, CA). Lipid percentage maps were calculated from fat and water images acquired using a conventional spin-echo sequence using the Dixon method [4]. 350μL of hyperpolarized DHA was injected each mouse (n=4) at baseline and 2 weeks of MCD diet using a Hypersense (Oxford Instruments), as previously described [5]. C MRSI data was acquired using an EPSI readout, variable flip angle scheme, matrix size 16 x 8 x 8 and final voxel resolution of 6mm isotropic on a 3T GE MRI (GE Healthcare, Waukesha, WI) equipped with a multinuclear package and dual-tuned H-C imaging coil. MR data was processed offline using custom software written in IDL 8 (ITT Visual Information Solutions, CO, USA) and Matlab 2009b (MathWorks, MA, USA). Ratios of HP DHA and VitC were calculated from the peak integrals in 3D MRSI data. Mice were then sacrificed and liver tissue was sectioned for staining with hematoxylin and eosin (H&E, structure) and Oil Red (lipid presence). Livers of normal mice were used for histologic comparison.

Label-free metabolic imaging of non-alcoholic-fatty-liver-disease (NAFLD) liver by volumetric dynamic optical coherence tomography

Molecular Imaging of Non-Alcoholic Fatty Liver Disease using an Endogenous Hyperpolarized Redox Sensor

Label-free functional and structural imaging of liver microvascular complex in mice by Jones matrix optical coherence tomography

Optical Tissue Diagnostics Based on Label-free, Functional Biomarkers

High-fidelity Imaging of Fatty Liver in Vivo with a Fluorescent and Photoacoustic Dual-Mode Probe by Taking Advantage of the Liver “first Pass Effect”

A proton nuclear magnetic resonance metabonomics approach for biomarker discovery in nonalcoholic fatty liver disease.

Advances in Optical Imaging of Nonalcoholic Fatty Liver Disease

Multimodal nonlinear optical imaging of obesity-induced liver steatosis and fibrosis

Quantitative assessment of hepatic steatosis using label-free multiphoton imaging and customized image processing program

Assessment of Nonalcoholic Fatty Liver Disease in Rats Using Quantitative Dynamic Contrast‐Enhanced MRI

3D Imaging of the Liver Extracellular Matrix in a Mouse Model of Non-Alcoholic Steatohepatitis

Near-infrared fluorescent probe for the imaging of viscosity in fatty liver mice and valuation of drug efficacy

Non‐Invasive 3D Photoacoustic Tomography of Angiographic Anatomy and Hemodynamics of Fatty Livers in Rats

Spatiotemporally quantitative in vivo imaging of mitochondrial fatty acid β-oxidation at cellular-level resolution in mice

Protein-encapsulated Long-Wavelength Fluorescent Probe Hybrid for Imaging Lipid Droplets in Living Cells and Mice with Non-Alcoholic Fatty Liver

Visualization and quantification of de novo lipogenesis using a FASN-2A-GLuc mouse model

Combination of two-photon fluorescent probes for carboxylesterase and ONOO − to visualize the transformation of nonalcoholic fatty liver to nonalcoholic steatohepatitis in liver orthotopic imaging

Real Time Measurement of Hepatic β‐oxidation with Deuterium Magnetic Resonance in Murine Models on a High Fat Diet

Recent Progress in Small Molecule Fluorescent Probes for Imaging and Diagnosis of Non-Alcoholic Fatty Liver Disease

Deep Learning-Based Image Analysis of Liver Steatosis in Mouse Models

Label-Free Imaging Techniques to Evaluate Metabolic Changes Caused by Toxic Liver Injury in PCLS